Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. The drugmaker is ...

Eli Lilly said last night it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation ...

Hospitals affiliated with Mount Sinai, the University of Michigan and the University of Kansas allege that CVS artificially ...

OPINION—There are many barriers to equitable health care in California, the cost of prescription drugs being central among ...

When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients ...

In April, members of Congress questioned hospital CEOs about the rising cost of health care - and particularly criticized ...

With post-pandemic Medicaid enrollments on the decline and expected to fall further, revenue cycle leaders warn that ...

Effective compliance now spans transaction eligibility, OPAIS synchronization, Medicaid exclusion validation, cost-report ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

One of the critical components for Mainers as they navigate the medical quagmire of insurance, providers and treatment is obtaining effective and safe drugs. Cancer treatment is often a long, taxing ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

The 340B program allows eligible clinics to purchase medications at a substantial discount, at no cost to taxpayers.